MAI Capital Management
Position in LCTX — Lineage Cell Therapeutics, Inc.
CIK 1040197
INDEPENDENCE, OH
Position in LCTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$18,856
-$6,232 QoQ
Shares Held
14,394
-9.4% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#84
of 130 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LCTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MAI Capital Management holds $23,626,176 across 53 Biotechnology names. LCTX ranks #49 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
6,715 | $4,187,071 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,638 | $2,800,563 | |
| 3 | DNLI |
Denali Therapeutics Inc.
|
49,160 | $1,264,394 | |
| 4 | INCY |
Incyte Corp
|
10,126 | $1,147,882 | |
| 5 | TRVI |
Trevi Therapeutics, Inc.
|
56,130 | $1,046,824 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
5,147 | $963,929 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
2,963 | $936,574 | |
| 8 | EXEL |
Exelixis, Inc.
|
13,982 | $760,760 |
All Filings in LCTX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,856 | 14,394 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $25,088 | 15,879 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $27,757 | 16,621 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $31,124 | 18,417 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $17,339 | 19,054 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $28,975 | 64,391 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $328,839 | 657,679 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,523,957 | 1,674,679 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $1,638,772 | 1,638,772 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,206,475 | 1,490,862 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $876,191 | 803,845 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $1,126,531 | 954,688 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,341,724 | 951,578 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $637,672 | 425,115 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $534,475 | 456,817 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $589,713 | 521,870 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $391,421 | 247,735 | Shares | Sole | 2022-07-19 | |
| No filing history on record for this holder in this stock. | ||||||